Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.
作者信息
Cooper D K, Good A H, Ye Y, Koren E, Oriol R, Ippolito R M, Malcolm A J, Neethling F A, Romano E, Zuhdi N
机构信息
Oklahoma Transplantation Institute, Baptist Medical Center, Oklahoma City 73112.